Resumen
Se hizo un estudio comparativo de la capacidad del Δ9-tetrahidro-cannabinol y de sus metabolitos monohidroxilados en producir effectos similares a los de la marihuana cuando son inyectados intravenosamente a humanos. Se encontro que la hidroxilacion en la posición 11 no cambio la potencia, en la posición 8β la redujo, y en la posición 8α la abolio por completo.
References
M. E. Wall, Ann. N.Y. Acad. Sci.191, 23 (1971).
M. E. Wall andM. Perez-Reyes, J. Am. chem. Soc., in press (1973).
H. D. Christensen, R. I. Freudenthal, J. T. Gidley, R. Rosenfeld, G. Boegli, L. Testino, D. R. Brine, C. G. Pitt, M. E. Wall, Science172, 165 (1971).
Z. Ben Zvi, R. Mechoulam, H. Edery, G. Porath, Science174, 951 (1971).
M. Perez-Reyes, M. C. Timmons, M. A. Lipton, K. H. Davis, M. E. Wall, Science177, 633 (1972).
Author information
Authors and Affiliations
Additional information
These studies were conducted under Contract No. HSM-42-71-95 between the Center for Studies of Narcotic and Drug Abuse of the Division of Narcotic Addition and Drug Abuse, NIMH, and the Research Triangle Institute. In addition, this investigation was supported by Public Health service Research Grant No. RR-46 from the General Clinical Research Centers Branch of the Division of Research Resources. We thank Drs.Monique Braude and st.Szara, Center for Studies of Narcotic and Drug Abuse, NIMH, for their interest and encouragement of this program. We also thankCarolyn Bishop andDaynise Skeen for their technical assistance.
Rights and permissions
About this article
Cite this article
Rerez-Reyes, M., Timmons, M.C., Lipton, M.A. et al. A comparison of the pharmacological activity ofgD9-Tetrahydrocannabinol and its monohydroxylated metabolites in man. Experientia 29, 1009–1010 (1973). https://doi.org/10.1007/BF01930433
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01930433